• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《Curaçao 标准在儿科人群遗传性出血性毛细血管扩张症诊断中的适用性》。

Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population.

机构信息

Division of Pediatric Hematology and Oncology, University of North Carolina School of Medicine, Chapel Hill, NC.

Department of Biostatistics, University of North Carolina-Chapel Hill, Chapel Hill, NC.

出版信息

J Pediatr. 2018 Jun;197:207-213. doi: 10.1016/j.jpeds.2018.01.079. Epub 2018 Apr 11.

DOI:10.1016/j.jpeds.2018.01.079
PMID:29655863
Abstract

OBJECTIVE

To evaluate the accuracy of the clinical Curaçao criteria in the diagnosis of hereditary hemorrhagic telangiectasia (HHT) in children and adolescents.

STUDY DESIGN

This was a retrospective, multicenter chart review of 673 patients evaluated between 2002 and 2016; 290 were eligible for the study. Genetic testing for a pathogenic mutation was considered the gold standard against which the clinical Curaçao criteria were compared. Patients were divided into 4 age categories: 0-5, 6-10, 11-15, and 16-21-years. Sensitivity and specificity were calculated for each age group, and for the overall population.

RESULTS

Overall the Curaçao criteria had a sensitivity of 68% (95% CI 60%-76%) and a specificity of 98% (95% CI 91%-100%). Sensitivity was lowest in the 0- to 5-year group, and increased with advancing age. The Curaçao criteria had the highest sensitivity in the 16- to 21-year-olds. Specificity was 100% in all age groups except for the 11- to 15-year-olds.

CONCLUSIONS

This study evaluated the use of the Curaçao criteria for the diagnosis of HHT in the pediatric population with a family history of HHT. In those between the age of 0 and 21 years who meet 1 criterion (unlikely HHT) or 2 criteria (possible HHT), genetic testing is preferred for diagnosis. The Curaçao criteria appear to reliably diagnose HHT in children and adolescents who meet 3 or 4 criteria (definite HHT).

摘要

目的

评估临床 Curaçao 标准在儿童和青少年遗传性出血性毛细血管扩张症(HHT)诊断中的准确性。

研究设计

这是一项回顾性、多中心病历回顾研究,共纳入 2002 年至 2016 年间评估的 673 例患者,其中 290 例符合研究条件。致病性突变的基因检测被认为是金标准,将其与临床 Curaçao 标准进行比较。患者被分为 4 个年龄组:0-5 岁、6-10 岁、11-15 岁和 16-21 岁。计算每个年龄组和总体的敏感性和特异性。

结果

总体而言,Curaçao 标准的敏感性为 68%(95%CI 60%-76%),特异性为 98%(95%CI 91%-100%)。0-5 岁组的敏感性最低,随年龄增长而增加。Curaçao 标准在 16-21 岁组的敏感性最高。除 11-15 岁组外,所有年龄组的特异性均为 100%。

结论

本研究评估了 Curaçao 标准在有 HHT 家族史的儿科人群中用于诊断 HHT 的应用。对于年龄在 0-21 岁之间符合 1 项标准(不太可能为 HHT)或 2 项标准(可能为 HHT)的患者,建议进行基因检测以明确诊断。Curaçao 标准似乎可可靠地诊断符合 3 或 4 项标准(明确为 HHT)的儿童和青少年的 HHT。

相似文献

1
Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population.《Curaçao 标准在儿科人群遗传性出血性毛细血管扩张症诊断中的适用性》。
J Pediatr. 2018 Jun;197:207-213. doi: 10.1016/j.jpeds.2018.01.079. Epub 2018 Apr 11.
2
Longitudinal Assessment of Curaçao Criteria in Children with Hereditary Hemorrhagic Telangiectasia.库拉索标准对遗传性出血性毛细血管扩张症患儿的纵向评估
J Pediatr. 2023 Dec;263:113665. doi: 10.1016/j.jpeds.2023.113665. Epub 2023 Aug 11.
3
Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2).库拉索遗传性出血性毛细血管扩张症诊断标准高度预测 ENG 或 ACVRL1 (HHT1 和 HHT2)中的致病性变异。
Genet Med. 2020 Jul;22(7):1201-1205. doi: 10.1038/s41436-020-0775-8. Epub 2020 Apr 17.
4
[Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].遗传性出血性毛细血管扩张症(奥斯勒-韦伯-伦杜病)的基因诊断
Orv Hetil. 2019 May;160(18):710-719. doi: 10.1556/650.2019.31380.
5
Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者脑动静脉畸形的临床表现及治疗模式
J Clin Neurosci. 2018 May;51:22-28. doi: 10.1016/j.jocn.2018.01.019. Epub 2018 Feb 23.
6
Localization and age distribution of telangiectases in children and adolescents with hereditary hemorrhagic telangiectasia: A retrospective cohort study.遗传性出血性毛细血管扩张症患儿和青少年的毛细血管扩张症的定位和年龄分布:一项回顾性队列研究。
J Am Acad Dermatol. 2019 Oct;81(4):950-955. doi: 10.1016/j.jaad.2018.11.014. Epub 2019 Feb 25.
7
Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.ENG、ACVRL1 和 SMAD4 基因突变与遗传性出血性毛细血管扩张症的临床表现:来自乌普萨拉大学医院奥尔斯勒病中心的经验。
Ups J Med Sci. 2018 Sep;123(3):153-157. doi: 10.1080/03009734.2018.1483452. Epub 2018 Sep 25.
8
ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症家族中的ENG突变嵌合体
Mol Genet Genomic Med. 2018 Jan;6(1):121-125. doi: 10.1002/mgg3.361. Epub 2017 Dec 14.
9
Hereditary hemorrhagic telangiectasia: how accurate are the clinical criteria?遗传性出血性毛细血管扩张症:临床标准的准确性如何?
Am J Med Genet A. 2013 Mar;161A(3):461-6. doi: 10.1002/ajmg.a.35715. Epub 2013 Feb 8.
10
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.在对200名接受遗传性出血性毛细血管扩张症(HHT)临床基因检测的个体进行的研究中,发现ENG和ACVRL1基因的新突变:基因型与表型的相关性。
Hum Mutat. 2006 Jul;27(7):667-75. doi: 10.1002/humu.20342.

引用本文的文献

1
A Rare Case of Intracranial Hemorrhage Mimicking a Neoplasm in a Child With Hereditary Hemorrhagic Telangiectasia.1例罕见的颅内出血病例,该患儿患有遗传性出血性毛细血管扩张症,颅内出血表现类似肿瘤。
Cureus. 2025 Jul 5;17(7):e87340. doi: 10.7759/cureus.87340. eCollection 2025 Jul.
2
Clinical Phenotypes of a Pediatric Cohort with -Related Hereditary Hemorrhagic Telangiectasia.患有相关遗传性出血性毛细血管扩张症的儿科队列的临床表型
J Clin Med. 2025 May 12;14(10):3359. doi: 10.3390/jcm14103359.
3
Specifications of the ACMG/AMP Variant Curation Guidelines for Hereditary Hemorrhagic Telangiectasia Genes- and .
遗传性出血性毛细血管扩张症基因的ACMG/AMP变异整理指南规范 - 以及
Hum Mutat. 2024 May 18;2024:3043736. doi: 10.1155/2024/3043736. eCollection 2024.
4
Hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症
Nat Rev Dis Primers. 2025 Jan 9;11(1):1. doi: 10.1038/s41572-024-00585-z.
5
Respiratory Tract Infection Leading to the Diagnosis of Hereditary Hemorrhagic Telangiectasia in a Puerto Rican Patient: A Case Report.呼吸道感染导致一名波多黎各患者被诊断为遗传性出血性毛细血管扩张症:病例报告
Cureus. 2024 Aug 23;16(8):e67638. doi: 10.7759/cureus.67638. eCollection 2024 Aug.
6
Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)中毛细血管扩张和实体器官动静脉畸形形成的遗传决定因素研究。
Int J Mol Sci. 2024 Jul 12;25(14):7682. doi: 10.3390/ijms25147682.
7
The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family.ENG/VEGFα 通路可能受内皮糖蛋白(ENG)/CD105 无义变异的影响,导致一个中国家族发生遗传性出血性毛细血管扩张症 1 型(HHT1)。
Genes (Basel). 2024 Feb 27;15(3):304. doi: 10.3390/genes15030304.
8
Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症患者抗凝处方的药物基因组学考量
J Clin Med. 2023 Dec 15;12(24):7710. doi: 10.3390/jcm12247710.
9
Executive summary of the 14th HHT international scientific conference.第十四届 HHT 国际科学会议执行摘要。
Angiogenesis. 2023 Aug;26(Suppl 1):27-37. doi: 10.1007/s10456-023-09886-5. Epub 2023 Sep 11.
10
Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review.一名42岁埃塞俄比亚男子患遗传性出血性毛细血管扩张症,伴有严重贫血和高输出量心力衰竭:病例报告及文献综述
Clin Case Rep. 2023 Jul 12;11(7):e7694. doi: 10.1002/ccr3.7694. eCollection 2023 Jul.